Tuatara Capital is a venture capital and private equity firm investing in the legal cannabis industry that is headquartered in New York City, New York and was founded in 2014 by mark Zittman, Al Foreman, and Marc Riiska. According to the company's LinkedIn page (as of November 2019), Tuatara Capital is managing more than $330 million in assets related to the cannabis industry.
Tuatara Capital focuses in investing in several sectors of the legal cannabis industry which include: research & testing, cultivation, processing, consumer & retail, technology, and industrial services. Notable investments made by Tuatara Capital include: GCH, Teewinot Life Sciences, Green dot labs, Slang Worldwide, Inc., The CanAscen Group, Enlighten, Connecticut Pharmaceutical Solutions, Sumpaz Enterprises, CannaKids, Green Flower Media, Willow Biosciences, Demetrix, and Hana.
On March 21, 2016 Tuatara Capital raised $37 million for their first venture capital fund dedicated to investing in the cannabis industry.
On May 16, 2019 Tuatara Capital announced raising more than $206 million for their second venture capital fund.
Pharmaceutical company that manufactures and licenses technology to make cannabinoid based therapies.